Featured Research

from universities, journals, and other organizations

Well-educated Women Hardest Hit By Breast Cancer

Date:
October 24, 2009
Source:
Monash University
Summary:
Well-educated women and those who live alone are emotionally the hardest hit by breast cancer, according to new findings. The study found that older women tended to experience lower levels of overall well-being compared to women of similar age in the community two years after their diagnosis.

Well-educated women and those who live alone are emotionally the hardest hit by breast cancer, according to the findings of a new Australian study announced during October's Breast Cancer Awareness Month.

The MBF Foundation Health and Wellbeing after Breast Cancer Study, undertaken by Monash University Medical School's Women's Health Program, found that older women tended to experience lower levels of overall wellbeing compared to women of similar age in the community two years after their diagnosis.

"Up until now, there has been uncertainty about exactly what the impact of being diagnosed with breast cancer is in terms of mood and wellbeing over time. In our study, we found that two years post diagnosis women with breast cancer were not more likely to be depressed but were more likely to experience a lowered sense of control over their life, and lower general health, with lessened vitality being limited to older women," explains Dr Susan R Davis, Professor of Women's Health, Monash University Medical School, who was involved in the study.

"The experience of having breast cancer is a personal one and is often accompanied by very complex emotions due to the fact that it strikes at a woman's very sense of self, purpose and sexuality."

Co-chief investigator of the study, Associate Professor Robin Bell, added: "That women living alone were more likely to have a lower wellbeing is a novel and important finding and would suggest that such women may benefit by targeted provision of social support."

More educated women are likely to be the best informed about their breast cancer and treatment, and their lower wellbeing results may reflect greater anxiety over decision making and their difficulty coping with a sense loss of control over their health and wellbeing.

"We would encourage health care providers to be sensitive to the fact that more highly educated women may deal less well with psychological aspects of their disease than others," said Professor Davis.

Breast cancer is the most common cancer among women in Australia, affecting one in nine women by the age of 85 years, and is responsible for around 2,600 deaths annually. With improvements in detection and treatment of breast cancer, 87 per cent of women affected survive five years or more from the time of detection.

"At MBF Foundation we are all for women becoming advocates for their breast cancer and their health in general but, as this study has shown, it is important that providing accurate information isn't at the expense of supporting their emotional needs," commented Dr Christine Bennett, Bupa Australia Chief Medical Officer and Chair of the MBF Foundation steering committee, which has committed $300,000 to fund the study.

"As survival prospects for women with breast cancer continue to improve, we shouldn't lose sight of the fact that each woman's journey and coping mechanisms are different. We know from listening to the women in the study, that it is common for breast cancer survivors to experience a range of emotions and concerns once treatment ends. Indeed, some women, report experiencing feelings of isolation and abandonment once their regular appointments with their medical team stop," added Dr Bennett.

On a positive note, the study found that women's wellbeing two years out from being treated for the disease was overall only modestly lower than for Australian women in general.

Women who are struggling with their emotions following breast cancer treatment may benefit from sharing their feelings with those close to them and discussing their concerns with a health professional or breast cancer support group.


Story Source:

The above story is based on materials provided by Monash University. Note: Materials may be edited for content and length.


Cite This Page:

Monash University. "Well-educated Women Hardest Hit By Breast Cancer." ScienceDaily. ScienceDaily, 24 October 2009. <www.sciencedaily.com/releases/2009/10/091019122952.htm>.
Monash University. (2009, October 24). Well-educated Women Hardest Hit By Breast Cancer. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/10/091019122952.htm
Monash University. "Well-educated Women Hardest Hit By Breast Cancer." ScienceDaily. www.sciencedaily.com/releases/2009/10/091019122952.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins